Medicus Pharma Ltd.
Carolyn Bonner currently serves as President of Medicus Pharma Ltd. since September 2023. Prior to this role, Carolyn held various positions at Parkway Clinical Laboratories, Inc. from August 2013 to August 2023, including President & CEO, President, Senior Vice President of Marketing & Sales, Vice President of Marketing & Sales, and Director of Marketing & Sales. Carolyn also contributed as Director of Corporate Development at Building Beyond BRIC Investment Fund from January 2010 to January 2012, focusing on fundraising, marketing, and back office operations. Earlier career experience includes serving as Director of Corporate Development at Rosetta Genomics and Director of Business Development at Parkway Clinical Laboratories. Carolyn began professional work in sales at Lakewood Pathology Associates from 2006 to 2007. Carolyn holds a Bachelor of Science degree in Marketing from West Chester University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Medicus Pharma Ltd.
Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities where an unmet need exists for improved patient safety and efficacy. Medicus is opportunisticly exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.